Detalles de la búsqueda
1.
Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial.
Am J Respir Crit Care Med
; 208(9): 917-929, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37703083
2.
Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged ≥12 years - The RECOVER study.
J Cyst Fibros
; 2023 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806792
3.
Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-ß2.
Sci Rep
; 12(1): 9564, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35689009
4.
Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro.
Sci Rep
; 12(1): 8299, 2022 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35585182
5.
Author Correction: Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro.
Sci Rep
; 12(1): 12924, 2022 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35902722
Resultados
1 -
5
de 5
1
Próxima >
>>